We have observed
16 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after February 01, 2014).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
CONTINUOUS EXTENSION AND DEBLOCKING IN REACTIONS FOR NUCLEIC ACID SYNTHESIS AND SEQUENCING
SLEEVE FOR A SMOKING ARTICLE
NANOPARTICLES AND USES THEREOF
METHODS AND SYSTEMS FOR DETERMINING HAPLOTYPES AND PHASING OF HAPLOTYPES
TRANSPOSON END COMPOSITIONS AND METHODS FOR MODIFYING NUCLEIC ACIDS
TRANSDERMAL DELIVERY OF SILDENAFIL AND OTHER PHOSPHODIESTERASE TYPE 5 INHIBITORS
TRANSDERMAL FORMULATIONS OF FLUTICASONE
MATERIALS, SYSTEMS, DEVICES, AND METHODS FOR ENDOLUMINAL ELECTROPOLYMERIC PAVING AND SEALING
METHODS OF DELIVERING NANOSHELLS INTO SEBACEOUS GLANDS
APPARATUS AND METHOD FOR SEPARATING AND CONCENTRATING FLUIDS CONTAINING MULTIPLE COMPONENTS
IMPROVED METHODS OF NUCLEIC ACID SEQUENCING
OLIGONUCLEOTIDE REPLACEMENT FOR DI-TAGGED AND DIRECTIONAL LIBRARIES
FIXED CHAMBER SEPARATOR WITH ADJUSTMENT WITHDRAWAL MEMBER